The blood urea nitrogen diagnostics market is anticipated to record a CAGR of 2% during the forecast period. The blood urea nitrogen diagnostics market recorded a value of US$ 43 Bn in 2022.
The demand for blood urea nitrogen diagnostics is anticipated to rise as the blood urea nitrogen diagnostics test is widely used to assess if the quantity of nitrogen in the blood is higher than normal, which has various uses in recent times.
| Attributes | Details |
| Blood Urea Nitrogren Diagnostics Market CAGR | 2% |
| Blood Urea Nitrogren Diagnostics Market Value (2022) | US$ 43 Bn |
In addition, rising sales of blood urea nitrogen diagnostics can also be attributed to its usage in determining the effectiveness of dialysis treatments such as hemodialysis or peritoneal dialysis.
The report sheds light on the factors improving the demand for blood urea nitrogen diagnostics and, in turn, the sales of blood urea nitrogen diagnostics.
However, the blood urea nitrogen diagnostics market also faces some challenges, limiting the demand for blood urea nitrogen diagnostics from reaching its potential.
Other conditions such as liver damage, obstruction in the urinary tract, congestive heart failure, and gastrointestinal bleeding can also be asses using the blood urea nitrogen diagnostics, thereby surging the demand for blood urea nitrogen diagnostics.
Due to an increase in the number of kidney diseases and the introduction of new point-of-care tests to diagnose renal diseases, the global sales of blood urea nitrogen diagnostics are expected to grow significantly during the forecast period.
As the number of patients with renal diseases worldwide rises, focusing on emerging markets presents an opportunity for major players, thereby augmenting their blood urea nitrogen diagnostics market share.
People's life expectancy has increased as a result of medical advancements, implying that a greater number of people are living past the age of 50, and the aging population is pushing a large number of people into the higher illness category, which necessitates ongoing medical care thereby spiking the sales of blood urea nitrogen diagnostics.
The most common risk factors for the development of kidney diseases are changing demographics and lifestyles. This factor is expected to drive up the global demand for blood urea nitrogen diagnostics.
During the forecast period, advancements in the measurement of blood urea nitrogen can also be credited for higher demand for blood urea nitrogen diagnostics and, in turn, sales of blood urea nitrogen diagnostics.
Some of the factors propelling the sales of blood urea nitrogen diagnostics include rising incidents of kidney damage and a few other similar ailments.
The growing demand for blood urea nitrogen diagnostics can also be attributed to the wide range of applications, including old age, obstruction in the urinary tract, recent heart attack, or congestive heart failure.
Bleeding in the gastrointestinal, dehydration, trauma, severe burns, adoption of a high protein diet, and intake of certain antibiotics are also considered major fields of application that provide impetus to the sales of blood urea nitrogen diagnostics.
Thus, a rise in the above conditions among the population creates a large pool of patients, thereby driving the overall demand for blood urea nitrogen diagnostics around the globe.
As the number of patients with renal diseases worldwide rises, focusing on emerging markets presents an opportunity for major players in the market to augment their blood urea nitrogen diagnostics market share.
The rising incidence of cardiovascular diseases in North America, the trend of regular health checks is providing a great deal of impetus to the demand for blood urea nitrogen diagnostics in the region.
Favorable reimbursement policies are also a major factor propelling the region's sales of blood urea nitrogen diagnostics.
However, as medical tourism for dialysis grows in APAC countries like India, the blood urea nitrogen diagnostics market in the region grows at a significantly faster rate than in other regions resulting in higher demand for blood urea nitrogen diagnostics.
In the region, sales of blood urea nitrogen diagnostics are exhibiting an upward trajectory as there has been an increase in the prevalence of kidney diseases, as well as a large number of elderly people suffering from kidney disease.
Some of the key players in the blood urea nitrogen diagnostics market include Pointe Scientific, Inc., Accurex Biomedical Pvt. Ltd., Invitrogen, Beacon Diagnostics Pvt. Ltd., Thermo Fisher Scientific, Eagle Biosciences, Inc., XpressBio, and Bioo Scientific Corporation, among others.
| Report Attribute | Details |
| Base year for estimation | 2021 |
| Historical data | 2014 - 2020 |
| Forecast period | 2022 - 2032 |
| Quantitative units | Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis |
| Segments covered | Type, application, end use, region |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
| Country scope | U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
| Key companies profiled | Pointe Scientific, Inc., Accurex biomedical Pvt. Ltd., Invitrogen, Beacon Diagnostics Pvt. Ltd., Thermo Fisher Scientific, Eagle Biosciences, Inc., XpressBio, and Bioo Scientific Corporation, among others |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Pointe Scientific, Inc., Accurex biomedical Pvt. Ltd., Invitrogen, Beacon Diagnostics Pvt. Ltd. are a few players holding major urea nitrogen diagnostics market share.
- The trend of regular health checks is providing impetus to the sales of blood urea nitrogen diagnostics contributing to the region’s high blood urea nitrogen diagnostics market share.
The wide range of applications associated with the blood urea nitrogen diagnostics is considered as a major propeller.
Explore Similar Insights
Blood Urea Nitrogen Diagnostics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
